Canis ISSN: 2398-2942

Chondroitin sulfate

Synonym(s): Chondroitin sulphate, CS

Introduction

Name

  • Chondroitin sulfate.

Class of drug

  • Glycosaminoglycan.
  • Nutraceutical.

Description

Storage requirements

  • Store in a dry place <25°C.
  • Keep container tightly closed.

Uses

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Indications

  • Nutritional aid in the management of degenerative joint disease.

Administration

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Pharmocokinetics

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Precautions

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Adverse Reactions

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Further Reading

Publications

Refereed papers

  • Recent references fromPubMed.
  • Lenox C E, Lunn K F (2010)Effects of glucosamine-chondroitin sulfate supplementation on serum fructosamine concentration in healthy dogs.JAVMA236(2), 183-186PubMed.
  • Sauve F, Paradis M, Refsal K R, Moreau M, Beauchamp G & Dupois J (2003)Effects of oral administration of meloxicam, carprofen and a nutraceutical on thyroid function in sdogs iwth osteoarthritis.Can Vet J44(6), 474-479PubMed.
  • Adebowale A, Du J, Liang Z, Leslie J L & Eddington N D (2002)The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulfate after single and multiple doses to beagle dogs.Biopharm Drug Dispos23(6), 217-225PubMed.
  • Canapp S O, McLaughlin R M, Hoskinson J J, Roush J K & Butine M D (2000)Scintigraphic evaluation of glucosamine HCl and chondroitin sulfate as treatment for acute synovitis in dogs.Am J Vet Res60(12), 1552-1557PubMed.
  • Booth D M (1998)Nutraceuticals in veterinary medicine. Part II. Safety and efficacy.Comp Contin Educ Pract Vet20(1), 15-21.
  • Booth D M (1997)Nutraceuticals in veterinary medicine. Part I. Definitions and regulations.Comp Contin Educ Pract Vet19(12), 1248-1255.
  • McNamara P S, Barr S C & Erb H N (1996)Hematologic, hemostatic and biochemical effects in dogs receiving an oral chondroprotective agent for thirty days.Am J Vet Res57(9), 1390-1394PubMed.

Other sources of information

  • McIlwraith C W (1999)Should I recommend the use of oral glycosaminoglycans?Comp Contin Educ Pract Vet21(5), 450-457.

ADDED